The Enterprise Value as of December 2024 (TTM) for Myriad Genetics, Inc. (MYGN) is 1.29B

According to Myriad Genetics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.29B. This represents a change of -38.78% compared to the average of 2.10B of the last 4 quarters.

Myriad Genetics, Inc. (MYGN) Historical Enterprise Value (quarterly & annually)

How has MYGN Enterprise Value performed in the past?

The mean historical Enterprise Value of Myriad Genetics, Inc. over the last ten years is 1.80B. The current 1.29B Enterprise Value has changed 7.03% with respect to the historical average. Over the past ten years (40 quarters), MYGN's Enterprise Value was at its highest in in the September 2018 quarter at 3.29B. The Enterprise Value was at its lowest in in the June 2020 quarter at 977.06M.

Myriad Genetics, Inc. (MYGN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Myriad Genetics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Myriad Genetics, Inc. (MYGN) Average Enterprise Value

How has MYGN Enterprise Value performed in the past?

The current Enterprise Value of Myriad Genetics, Inc. (MYGN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Myriad Genetics, Inc. (MYGN) Enterprise Value vs. Peers

How is MYGN’s Enterprise Value compared to its peers?

Myriad Genetics, Inc.’s Enterprise Value is less than Guardant Health, Inc. (4.49B), greater than CareDx, Inc (1.06B), less than Invitae Corporation (1.36B), greater than Castle Biosciences, Inc. (701.42M), less than Sotera Health Company (5.83B), less than Syneos Health, Inc. (7.24B), less than Neogen Corporation (3.40B), less than RadNet, Inc. (6.36B), less than Natera, Inc. (20.97B), less than Medpace Holdings, Inc. (10.01B), greater than Personalis, Inc. (389.71M), less than Qiagen N.V. (10.89B), less than Olink Holding AB (publ) (3.16B), greater than Aclaris Therapeutics, Inc. (158.78M), less than Exact Sciences Corporation (13.08B), less than Illumina, Inc. (23.21B), less than Twist Bioscience Corporation (2.71B),

Build a custom stock screener for Myriad Genetics, Inc. (MYGN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Myriad Genetics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Myriad Genetics, Inc. (MYGN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Myriad Genetics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.